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Nowadays, optical coherent tomography (OCT) as the most precise morphologic technique
is used in the increasing number of cases, both in routine clinical situations and research
projects. Huang and co-workers reported the first clinical use of the 2-dimensional OCT in
1991, suggesting the principle of its use both in ophthalmology and interventional
cardiology. The method has developed rapidly since that time. Interventional cardiologists
benefit from its detailed intravascular imaging ability, providing real-time information of
the intracoronary pathology. Researchers acknowledge the resolution, allowing detailed
analysis of vessel structure. Its axial resolution level is approximately 10–15 mm, which is
far from any other method used in interventional cardiology. The review will address the
principle of the method and the main fields of the relatively short history of the OCTuse as
a routine clinical imaging method. We will summarize the main OCT milestones in the
research field and its possible future as well. The review will describe OCT as the method
under rapid development that should be considered as a new ‘‘gold’’ or even ‘‘platinum’’
standard for the coronary vessels imaging.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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Optical coherence tomography (OCT) is the intravascular
imaging method, that allows physicians to investigate struc-
ture of a vessel in a near to cellular level in vivo. From the
time of the first implantation of coronary stent in human in
1986 [1], cardiologists were trying to find ways how to
investigate coronary vessels in vivo from inside. The first
method used for this purpose was angioscopy [2], method
that allows only surface assessment of the vessel. First, truly
useful imaging modality for the vessel and stent analysis was
intravascular ultrasound (IVUS), developed in 70s [3]. For
many years, IVUS was a gold standard for both the vessel
wall and stent imaging. However, resolution of IVUS is about
ten times lower than the one of OCT and the limitations in
the assessment of stents (especially uselessness of IVUS as a
tool for the analysis of the stent tissue coverage) are not
negligible. The first clinical application of the 2-dimensional
OCT was reported by Huang and co-workers in 1991 [4],
suggesting the principle of its use both in ophthalmology
and interventional cardiology. The method has developed
rapidly since that time. Nowadays, OCT is used in the
increasing number of cases, both in routine clinical situations
and research projects. Interventional cardiologists benefit
from its detailed intravascular imaging ability, providing
real-time information of the intracoronary pathology.
Researchers acknowledge the resolution, allowing detailed
analysis of vessel structure. Its axial resolution level is
approximately 10–15 mm, which is far from any other method
used in interventional cardiology. The review will address the
main fields of the relatively short history of the OCTuse as a
routine imaging method (the first clinical use of OCT in US
was performed in May 2010 following the FDA approval) and
its future. We will summarize the main OCT milestones in
the research field as well. The review will describe OCT as the
method under rapid development that should be considered
as a new gold standard for the coronary vessels imaging.2. Principles of coronary OCT
OCT imaging is a light-based intravascular imaging technique.
The principle of the image creation is based on the back-
scattering of light from the vessel wall structures and the time
that light needs to travel from the source to the tissue
structure and back. Due to an extreme speed of light,
interferometry techniques are needed to measure the back-
scattered signal. Current OCT systems use a central wave-
length of approximately 1300 nm, which is very close to the
infrared light. The main advantage of the OCT method is
getting a very detailed picture of the vessel. The axial
resolution is 10–15 mm. This high resolution is a result of
wave velocity and the bandwidth, both orders of magnitude
higher that in the ultrasound medical devices. The lateral
resolution 20–40 mm is determined by the imaging optics in
the catheter. The tissue penetration of this wavelength is
limited to 1–3 mm. Compared to IVUS (tissue penetration of
4–8 mm), the vessel wall penetration of light might be one of
the main limitations of the OCT method. However, accordingto Kume et al. [5], intima-media thickness can be measured
more accurately by OCT than IVUS (depending on the vessel
diameter).
First commercially available OCT system (M2/M3 TD-OCT
Imaging system, LightLab/St. Jude Medical, St. Paul, Minnesota)
was based on the older technology, called time-domain OCT (TD-
OCT). The system is based on a broadband light source emitting
light through the fiberoptic coupler, dividing the signal to two
‘‘arms’’—one to the tissue, the second one to the reference arm
consisting of moving mirror calibrated to produce known echo
delays. The main pitfall of this system is a slow speed of the
frames acquisition (max. acquisition speed 3mm/s, mainly due
to a limitation of the movement speed of the mirror), which
results in need of a complete vessel occlusion with an over-the-
wire low-pressure occlusion balloon (Helios, Goodman, Nagoya,
Japan). Distal flush ports of the balloon are used to infuse saline
or Ringer’s lactate to displace blood during the imaging process.
Due to safety issues, the manufacturer limited the time of the
occlusion to maximum of 30 s. Safety was the reason why FDA
never approved TD-OCT system for a clinical use in US, contrary
to European Union (EU) countries, where TD-OCTwas introduced
to the market in 2007.
Newer system, termed frequency or Fourier-domain OCT
(FD-OCT) uses fixed mirror instead, because light is emitted
by a variable frequency source, called ‘‘swept-laser’’ (Fig. 1).
This difference allows the system to be significantly faster
(max. acquisition speed 20 mm/s) [6] (Table 1). Thus, no blood
flow occlusion is needed with this system, only a continuous
flush of the contrast fluid is enough to clear the vessel to gain
an uncompromised image.
FD-OCT system C7XR (St. Jude Medical, St. Paul, Minnesota;
Fig. 2) was the first FD-OCT system available for the clinical
use on the US market. FDA clearance of the method followed
in 2010 its former approval in EU, Asia and South America.
The system uses 2.7-F imaging catheter C7 DragonflyTM
(St. Jude Medical, St. Paul, Minnesota; Fig. 3), compatible with
0.014’’ guidewire and 6-F guiding catheters. Detailed descrip-
tion of the imaging procedure is out of the scope of this
article and is available elsewhere [7].
The feasibility of the procedure was increased with the
introduction of the FD-OCT technology, providing physicians
with completely new level of information about vessels and
stents in vivo. Despite the undisputed advantages of the OCT
as an imaging method, operator using this technique has to
be aware of its specific limitations. First of all, there is a
certain vessel size range that is suitable for OCT examination.
Ideally, the artery diameter should be 2.0–3.75 mm, since the
upper limit is based on the maximum scanning diameter of
the system. One of the most common causes of distortion of
the image is an extreme vessel tortuosity, causing the
catheter to be placed significantly eccentric in the lumen
[8]. Incomplete blood displacement from the vessel segment
leads to the severe attenuation of the image, compromising
the analysis as well (Fig. 4). Several types of the artifacts were
described [7], although introducing of the FD-OCT system
significantly decreased their occurrence. Especially artifacts
based on the slow image acquisition of the TD-OCT techni-
que (e.g., ‘‘sew-up’’ artifacts generated due to a movement of
the vessel during the one frame data acquisition) are sup-
pressed with the new system.
Fig. 1 – Scheme of the FD-OCT system (adapted from JACC Cardiovascular Intervention 2009 Nov;2(11):1035–46).
Table 1 – Comparison of physical characteristics of the TD-OCT, FD-OCT and IVUS systems.
TD-OCT (M2/M3)a FD-OCT (C7XR)
a IVUS b
Wavelength 1.3 mm 1.3 mm 35–80 mm
Axial resolution 12–15 mm 12–15 mm 100–200 mm
Lateral resolution 90 mm 20–40 mm 200–300 mm
Pullback speed 3 mm/s 20 mm/s 1 mm/s
Frame acquisition rate 20 frames/s 100 frames/s 30 frames/s
Max. scan diameter 6.8 mm 9.7 mm 15 mm
Tissue penetration 1.5–2 mm 2.5 mm 10 mm
a Based on specifications of the M2/M3 and C7XR OCT system.
b Based on specifications of Volcano, Boston Scientific and Terumo IVUS systems (Modified from Int J Cardiol (2012), http://dx.doi.org/10.1016/j.
ijcard.2012.02.013).
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C7XR system fixed to 54 mm. If longer vessel segment analysis
is needed, multiple overlapping pullbacks are performed.
When more than one pullback is obtained, analyst face a
potential problem of the overlapping segments identification.
Characteristic identifiable structures (e.g., side branches) are
used for this purpose.
Another common cause of an incorrect image analysis is the
wrong adjustment of the Z-offset. Calibration of this parameter
corrects the difference of the optical path between both (refer-
ence and sample) arms [7]. In C7XR TD-OCT system the outer
diameter of the semitransparent imaging catheter (0.90mm)
serves as the calibration reference dimension, ‘‘zero-point’’
setting of the system [9]. The Z-offset of the pullback has to be
indispensably adjusted before any quantitative measurement is
started; otherwise results are significantly compromised.3. OCT as a research tool
Analysis of the OCT image for the research purposes is a
significantly different process comparing to the routineclinical on-line use in a cathlab. Since the beginning of the
OCTavailability, the cornerstone of the OCTanalysis has been
in the stent coverage assessment. However, number of
suitable clinical situations and study endpoints where OCT
was successfully used is constantly rising.
Since 2007 (when TD-OCTwas first approved in EU), almost
40 clinical OCT studies focused on the stent coverage assess-
ment have been published [10]. Only few of the trials had
randomized design [11–17]. Most of the trials were single-
center, which is expected to change in the future, as the
availability of the OCT technology is rising in cathlabs. There
are several multicenter randomized OCT studies recruiting
patients now, e.g., OCTAVIA trial [18].
The offline analysis of the OCT pullbacks is a strenuous
work, if performed in a detailed ‘‘strut level’’ way. As the strut
level analysis make demands on personnel and time, it is
usually performed in one of the OCT corelabs with skilled and
experienced team of analysts. Generally, for one stent pull-
back, the number of struts that have to be analyzed is usually
more than one thousand, depending on the thickness of the
cross-section for the assessment. The offline analysis has
two parts—quantitative and qualitative. Whereas the
Fig. 2 – St. Jude/Lightlab C7XR FD-OCT system.
Fig. 3 – C7 DragonflyTM imaging catheter with the tip in
detail—note very short segment (arrows) used for the wire
guiding the catheter. The imaging area lies proximally from
this part, therefore the wire is found outside of the catheter
in the OCT cross-section image.
Fig. 4 – Example of the incomplete displacement of blood
(asterisks) from the vessel lumen, significantly
compromising the image quality.
Fig. 5 – Red thrombus (asterisks), characterized by the high
backscattering of the border and severe signal attenuation.
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tures displayed, the quantitative part is mostly the result of
manual tracing of the vessel lumen and stent struts position.
For now, no reliable software for the automatic segmentation
of the OCT frames commercially exists.
Based on the light backscattering, light attenuation and
structure displayed in the OCT pullback, type of the tissue is
determined by the qualitative analysis. The recognition of the
structure is crucial also for the on-line analysis in the cathlab,
as the cardiologist can use the information for the optimal
intervention technique choice. There are characteristic pat-
terns for the thrombus recognition, described as the irregular
structures inside the lumen with the high backscattering and
severe attenuation of signal (red thrombus, Fig. 5) or as the
low-backscattering structures (white thrombus) [19]. Lipid
plaque is characterized as a signal-attenuated structure with
a high backscattering diffuse border, usually with a smooth
surface (compared to thrombus, Fig. 6) [20,21]. Calcified
plaque is defined as a hyposignal region delineated by a
sharp boundary (Fig. 7) [22,23]. Normal physiological vessel
Fig. 7 – Large calcified plaque (asterisks), defined as a
hyposignal region delineated by a sharp boundary.
Fig. 8 – Almost normal vessel with no significant
disease—three layers wall structure.
Fig. 6 – Lipid-rich plaque in the severely diseased vessel
(white arrows), defined as a signal-attenuated structure
with a high backscattering diffuse border, usually with a
smooth surface. Fig. 9 – Vessel wall dissection in the proximity of the
proximal stent edge (arrow).
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of the wall (Fig. 8). Another structures usually described in
the analysis are protruded tissue or dissections [24,25] (Fig. 9).
Strut level analysis is based on the lumen and stent struts
position tracing. Surface of stent struts reflects light fully,
creating a bright signal, usually named as ‘‘blooming’’. Due to
the inability of light to pass through metal struts, a shadow is
seen behind the blooming. If baseline examination is per-
formed after the stent placement, struts are described as
apposed, malapposed or embedded (according to its position
towards the vessel wall). If formerly implanted stent is
analyzed during the follow-up period, it can be described as
covered, covered-protruding (disturbing lumen contour, but
covered), uncovered-apposed, and uncovered-malapposed
[26]. Due to a different nominal thickness of the struts in
different stents, the type of the stent needs to be known for
the proper assessment of the struts. The apposition of the
strut is preferably measured as the distance from the inner
surface of the strut blooming to the lumen of the vessel,
correcting for half of the thickness of the blooming (18 mm)
[8,26]. In clinical trials, analysts in corelab are usually blinded
to the stent type, thus the real strut position (apposed,
malapposed) is revealed after the statistical analysis.4. OCT as a daily tool
During the regular clinical examination in a cathlab, detailed
analysis of the stent struts, as performed offline, is incon-
ceivable. The on-site assessment of the acquired data is
limited by the patient presence on the examination table
and the necessity to proceed without any needless delay.
Therefore, the operator is able to perform only a standard
qualitative assessment of the pullback (diameter of the
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gical structures, vessel wall pathology etc.).
Most important information obtained from the pullback is a
vessel wall response to the stent implantation. OCT data allows
to assess the strut apposition or to analyze acute damage after
the stent implantation (e.g., tissue prolapse, intimal rupture,
vessel dissections or acute thrombus formation). OCT with its
resolution can even detect a fracture of the stent in vivo [27]. In
the follow-up period after the stent implantation, OCT is a
sovereign method for the strut tissue coverage assessment,
including the in-stent restenosis or stent thrombosis.
In the setting of the acute coronary syndrome (ACS), the OCT
imaging can provide valuable information about the vessel wall
structural pathology, minimal lumen diameter and area and
reference areas proximally and distally to the segment that is
about to be stented. Ino et al. [28] recently assessed culprit lesion
morphology in ACS patients and revealed significant differences
in the incidence of plaque rupture, thin-cap fibroatheroma, and
red thrombus in ST-segment elevation myocardial infarction
(STEMI) patients compared with those with nonST segment
ACS. Interesting finding in this study was the difference in the
ruptured plaque of which aperture was open-wide against the
direction of coronary flow significantly more often in STEMI
compared with nonST ACS.
After the stent placement, the OCT image of the strut
positions can make the operator to proceed with another
intervention (e.g., postdilatation of the lesion, if the stent
seems to be malapposed). Obviously, the physician can only
estimate, if the struts are apposed to the vessel wall, because
he usually cannot perform regular strut level analysis of the
stent due to a limited time (however, the nominal stent struts
thickness is known in this situation).
Decision making based on the OCT imaging (in fact, OCT
guided procedure) is one of the unsolved questions in the
cathlab. Only few studies addressed this problem, using OCT
either for the angiographically ambiguous lesions [29], or as a
complementary method with the fractional flow reserve (FFR)Fig. 10 – Pullback cross-sections after the thromboaspiration in t
(A)—Medial part of the stent, thrombi (asterisk), and malapposed
the stent, thrombus material filling the most of the lumen cros
malapposed stent struts (arrows) covered with material (most lto guide decision making in complex clinical scenarios [30].
Randomized trials are needed, attempting to prove if the OCT
imaging brings a real benefit to the patients’ care in term of
reduced morbidity and mortality.
As the experience has been rising with the OCT systems, as
well as the confidence in the method safety and feasibility,
novel applications of the OCT imaging appear. The successful
imaging of the carotid vessels was reported [31–33]. OCT
imaging of the peripheral vessels (both arteries and veins)
was described as well [34,35]. One of the uncommon applica-
tions of OCT in pulmonary arteries was reported recently [36].5. Case report
As an example of the routine clinical use of the OCT, we
present a case report of the 75 years old male, admitted to our
coronary care unit due to a severe chest pain lasting 4 hours.
The patient had a history of hypertension, peripheral
ischemic disease and ischemic heart disease. He experienced
a coronary stenting in different hospital due to the exertional
angina 8 months ago. First generation drug eluting stents
(DES) were implanted into two vessels—left circumflex (LCX)
and right coronary artery (RCA) during the percutaneous
intervention (PCI). The patient refers no ischemic symptoms
since the time of previous PCI until the day of admission. He
claimed that he used prescribed medication regularly (clopi-
dogrel, aspirin, statin, angiotensin II receptor blockers).
ECG revealed a pattern of the inferolateral STEMI and the
patient was immediately transferred to the cathlab. Occluded
LCX was found as a culprit lesion, treated with thromboaspira-
tion with the extraction of several red thrombi, followed by an
immediate TIMI3 flow restoration. OCT revealed residual throm-
botic material in the vessel, concentrated in the segment with
the malapposed struts of the DES implanted 8 months ago
(Fig. 10). The lesion was treated with platelet glycoprotein
receptors IIb/IIIa inhibitor and balloon postdilatation, subsequenthe STEMI patient (see the case report description in the text).
stent struts in the thrombus material. (B)—Proximal part of
s-section. (C)—Close to the proximal edge of the stent,
ikely thrombus).
Fig. 11 – Pullback cross-sections (corresponding with the cross-sections in the Fig. 9) after the balloon postdilatation in the
STEMI patient (see the case report description in the text). (A)–(C)—Small amount of residual thrombi. (C)—Note the change in
the stent apposition after the balloon postdilatation (compared to the baseline image 10C, arrows), still covered with residual
material.
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 1 6 7 – e 1 7 5 e173OCT record showed a small amount of residual thrombi and
acceptable stent apposition (Fig. 11). The physician responsible
for the intervention decided not to implant an additional stent
due to a satisfactory result of the balloon angioplasty verified
by OCT.
The patient was discharged from the hospital on day 5 with
no complications. Antiplatelet treatment was switched from
clopidogrel to prasugrel. This report shows very clearly how
important additional information can bring OCT image in the
decision-making process.6. Future of OCT in the interventional cardiology
As we demonstrated in the previous part of the text, OCT
imaging technique is constantly developing and opening new
horizons in the coronary interventions. Two other commer-
cial systems are planned to reach the market [37,38]. Devel-
opment of the software for the 3D reconstruction of the OCT
image is probably one of the most competing tasks in the
field, with few first reports published on the topic [39,40]. In
the near future, introduction of the micro-OCT system is
expected [41]. This system should provide extreme image
resolution (up to 1 mm). The resolution brings such a level of
detail, that the cellular structure of endothelial tissue should
be assessable. As each of the intravascular imaging techni-
ques (OCT, IVUS) and FFR has specific indications, advantages
and disadvantages, manufacturers try to combine these
methods into one compact device. Recently, new system to
combine FFR and OCT was approved for the clinical use
(ILUMIENTM, St.Jude Medical, St. Paul, MN). Another research
target is a semi-automatic or automatic analysis of the vessel.
In the future, an ideal system should display 3D reconstruc-
tion of the vessel, together with automatically analyzed
structures of the vessel wall, their diameters and volumetric
assessment.7. Conclusions
Optical coherence tomography is a high-resolution intravascular
imaging technique. Its research application is irreplaceable, but
the method is also an excellent routine clinical tool. In hands of
skilled and experienced interventional cardiologist OCT extends
the borders of the diagnostic options. No other method can
provide undisputable quality images in such a detail. The
technique is safe and easy to use. The constant development
of OCT could overcome its limitations and become a ‘‘ platinum’’
standard of the intracoronary imaging in the future. Further
research is needed to prove the patients’ benefit from the ‘‘OCT-
guided’’ procedures. One of the current important limitations of
the technique is relatively high price of the imaging catheter.Acknowledgment
Supported by the Grant of the IGA Ministry of Health of the
Czech Republic no. NT/13830 and NS9824-4/2008
r e f e r e n c e s
[1] U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, L. Kappenberger,
Intravascular stents to prevent occlusion and restenosis after
transluminal angioplasty, New England Journal of Medicine
316 (1987) 701–706.
[2] M.J. Suter, S.K. Nadkarni, G. Weisz, et al., Intravascular
optical imaging technology for investigating the coronary
artery, JACC Cardiovascular Imaging 4 (2011) 1022–1039.
[3] N. Bom, C.T. Lance´e, F.C. Van Egmond, An ultrasonic intra-
cardiac scanner, Ultrasonics 10 (1972) 72–76.
[4] D. Huang, E.A. Swanson, C.P. Lin, et al., Optical coherence
tomography, Science 254 (1991) 1178–1181.
[5] T. Kume, T. Akasaka, T. Kawamoto, et al., Assessment of
coronary intima–media thickness by optical coherence
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 1 6 7 – e 1 7 5e174tomography: comparison with intravascular ultrasound, Cir-
culation Journal 69 (2005) 903–907.
[6] S.R. Chinn, E.A. Swanson, J.G. Fujimoto, Optical coherence
tomography using a frequency-tunable optical source, Optics
Letters 22 (1997) 340–342.
[7] H.G. Bezerra, M.A. Costa, G. Guagliumi, A.M. Rollins, D.I.
Simon, Intracoronary optical coherence tomography: a com-
prehensive review clinical and research applications, JACC
Cardiovascular Intervention 2 (2009) 1035–1046.
[8] N. Suzuki, G. Guagliumi, H.G. Bezerra, et al., The impact of an
eccentric intravascular ImageWire during coronary optical
coherence tomography imaging, EuroIntervention 6 (2011)
963–969.
[9] F. Prati, E. Regar, G.S. Mintz, et al., Expert review document
on methodology, terminology, and clinical applications of
optical coherence tomography: physical principles, metho-
dology of image acquisition, and clinical application for
assessment of coronary arteries and atherosclerosis, Eur-
opean Heart Journal 31 (2010) 401–415.
[10] S. Tahara, D. Chamie´, M. Baibars, C. Alraies, M. Costa, Optical
coherence tomography endpoints in stent clinical investiga-
tions: strut coverage, International Journal of Cardiovascular
Imaging 27 (2011) 271–287.
[11] G. Guagliumi, G. Musumeci, V. Sirbu, et al., Optical coherence
tomography assessment of in vivo vascular response after
implantation of overlapping bare-metal and drug-eluting
stents, JACC Cardiovascular Intervention 3 (2010) 531–539.
[12] G. Guagliumi, M.A. Costa, V. Sirbu, et al., Strut coverage and late
malapposition with paclitaxel-eluting stents compared with
bare metal stents in acute myocardial infarction: optical
coherence tomography substudy of the harmonizing outcomes
with revascularization and stents in acute myocardial infarc-
tion (HORIZONS-AMI) trial, Circulation 123 (2011) 274–281.
[13] G. Guagliumi, V. Sirbu, H. Bezerra, et al., Strut coverage and
vessel wall response to zotarolimus-eluting and bare-metal
stents implanted in patients with ST-segment elevation
myocardial infarction: the OCTAMI (optical coherence tomo-
graphy in acute myocardial infarction) study, JACC Cardio-
vascular Interventions 3 (2010) 680–687.
[14] G. Guagliumi, V. Sirbu, G. Musumeci, et al., Strut coverage
and vessel wall response to a new-generation paclitaxel-
eluting stent with an ultrathin biodegradable abluminal
polymer: optical coherence tomography drug-eluting stent
investigation (OCTDESI), Circular Cardiovascular Interven-
tions 3 (2010) 367–375.
[15] P. Barlis, E. Regar, P.W. Serruys, et al., An optical coherence
tomography study of a biodegradable vs. durable polymer-
coated limus-eluting stent: a LEADERS trial sub-study,
European Heart Journal 31 (2010) 165–176.
[16] T. Adriaenssens, J. Dens, G. Ughi, et al., Optical coherence
tomography (OCT) in PCI for in-stent restenosis (ISR): ratio-
nale and design of the SEDUCE (safety and efficacy of a drug
eluting balloon in coronary artery restenosis) study, Euro-
Intervention 7 (Suppl K:K) (2011) 100–105.
[17] T.C. Poerner, S. Otto, J. Gassdorf, et al., A prospective rando-
mised study using optical coherence tomography to assess
endothelial coverage and neointimal proliferation at 6-
months after implantation of a coronary everolimus-eluting
stent compared with a bare metal stent postdilated with a
paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design
and methods, EuroIntervention 7 (Suppl K:K) (2011) 93–99.
[18] /www.clinicaltrials.govS.
[19] T. Kume, T. Akasaka, T. Kawamoto, et al., Assessment of
coronary arterial thrombus by optical coherence tomogra-
phy, American Journal of Cardiology 97 (2006) 1713–1717.
[20] T. Kume, T. Akasaka, T. Kawamoto, et al., Assessment of
coronary arterial plaque by optical coherence tomography,
American Journal of Cardiology 97 (2006) 1172–1175.[21] Y. Miyamoto, H. Okura, T. Kume, et al., Plaque characteristics
of thin-cap fibroatheroma evaluated by OCT and IVUS, JACC
Cardiovascular Interventions 4 (2011) 638–646.
[22] H. Yabushita, B.E. Bouma, S.L. Houser, et al., Characterization
of human atherosclerosis by optical coherence tomography,
Circulation 106 (2002) 1640–1645.
[23] T. Kubo, C. Xu, Z. Wang, N.S. Van Ditzhuijzen, H.G. Bezerra,
Plaque and thrombus evaluation by optical coherence tomogra-
phy, International Journal of Cardiovascular Imaging 27 (2011)
289–298.
[24] M. Radu, E. J½rgensen, H. Kelbæk, S. Helqvist, L. Skovgaard,
K. Saunama¨ki, Optical coherence tomography at follow-up
after percutaneous coronary intervention: relationship
between procedural dissections, stent strut malapposition
and stent healing, EuroIntervention 7 (2011) 353–361.
[25] T. Kume, H. Okura, Y. Miyamoto, et al., Natural history of
stent edge dissection, tissue protrusion and incomplete stent
apposition detectable only on optical coherence tomography
after stent implantation, Circular Journal 76 (2012) 698–703.
[26] E.A. Mehanna, G.F. Attizzani, H. Kyono, M. Hake, H.G.
Bezerra, Assessment of coronary stent by optical coherence
tomography, methodology and definitions, International
Journal of Cardiovascular Imaging 27 (2011) 259–269.
[27] P. Barlis, G. Sianos, G. Ferrante, F. Del Furia, S. D’Souza,
C. Di Mario, The use of intra-coronary optical coherence
tomography for the assessment of sirolimus-eluting stent
fracture, International Journal of Cardiology 136 (2009)
e16–20.
[28] Y. Ino, T. Kubo, A. Tanaka, et al., Difference of culprit lesion
morphologies between ST-segment elevation myocardial
infarction and non-ST-segment elevation acute coronary
syndrome: an optical coherence tomography study, JACC
Cardiovascular Interventions 4 (2011) 76–82.
[29] F. Imola, M.T. Mallus, V. Ramazzotti, et al., Safety and
feasibility of frequency domain optical coherence tomogra-
phy to guide decision making in percutaneous coronary
intervention, EuroIntervention 6 (2010) 575–581.
[30] G.T. Stefano, H.G. Bezerra, G. Attizzani, et al., Utilization of
frequency domain optical coherence tomography and fractional
flow reserve to assess intermediate coronary artery stenoses:
conciliating anatomic and physiologic information, Interna-
tional Journal of Cardiovascular Imaging 27 (2011) 299–308.
[31] S. Yoshimura, M. Kawasaki, K. Yamada, et al., OCT of human
carotid arterial plaques, JACC Cardiovascular Imaging 4 (2011)
432–436.
[32] B. Reimers, D. Nikas, E Stabile, et al., Preliminary experience
with optical coherence tomography imaging to evaluate
carotid artery stents: safety, feasibility and techniques,
EuroIntervention 7 (2011) 98–105.
[33] M.R. Jones, G.F. Attizzani, C.A. Given, 2nd, Brooks W.H., Costa
M.A., Bezerra H.G. Intravascular frequency-domain optical
coherence tomography assessment of atherosclerosis and
stent-vessel interactions in human carotid arteries. Amer-
ican Journal of Neuroradiology 2012; http://dx.doi.org/10.
3174/ajnr.A3016 [Epub ahead of print].
[34] T. Yonetsu, T. Kakuta, T. Lee, et al., Assessment of acute
injuries and chronic intimal thickening of the radial artery
after transradial coronary intervention by optical coherence
tomography, European Heart Journal 31 (2010) 1608–1615.
[35] G.T. Stefano, E. Mehanna, S.A. Parikh, Imaging a spiral
dissection of the superficial femoral artery in high resolution
with optical coherence tomography—seeing is believing,
Catheter Cardiovascular Intervention (2012), http://dx.doi.or
g/10.1002/ccd.24292 [Epub ahead of print].
[36] S. Tatebe, Y. Fukumoto, K. Sugimura, et al., Optical coherence
tomography as a novel diagnostic tool for distal type chronic
thromboembolic pulmonary hypertension, Circulation
Journal 74 (2010) 1742–1744.
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 1 6 7 – e 1 7 5 e175[37] T. Okamura, Y. Onuma, H.M. Garcia-Garcia, et al., First-in-
man evaluation of intravascular optical frequency domain
imaging (OFDI) of Terumo: a comparison with intravascular
ultrasound and quantitative coronary angiography, EuroIn-
tervention 6 (2011) 1037–1045.
[38] G. Guagliumi, V. Sirbu, Optical coherence tomography: high
resolution intravascular imaging to evaluate vascular healing
after coronary stenting, Catheter Cardiovascular Interven-
tion 72 (2008) 237–247.
[39] V. Farooq, T. Okamura, B.D. Gogas, et al., 3D reconstructions
of optical frequency domain imaging to improve understandingof conventional PCI, JACC Cardiovascular Imaging 4 (2011)
1044–1046.
[40] S. Tu, L. Xu, J. Ligthart, et al. In vivo comparison of arterial
lumen dimensions assessed by co-registered three-dimen-
sional (3D) quantitative coronary angiography, intravascular
ultrasound and optical coherence tomography. International
Journal Cardiovascular Imaging 2012; http://dx.doi.org/10.
1007/s10554-12-0016-6 [Epub ahead of print].
[41] L. Liu, J.A. Gardecki, S.K. Nadkarni, et al., Imaging the
subcellular structure of human coronary atherosclerosis
using micro-optical coherence tomography, Nature Medicine
17 (2011) 1010–1014.
